Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-030886
Filing Date
2016-10-24
Accepted
2016-10-24 19:11:36
Documents
2
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4069
2 ex24gollust.txt EX-24 4391
  Complete submission text file 0001179110-16-030886.txt   9921
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 161949053